Physician profile
Derek Brumley
NPI 1851787899
$816.87
in general payments reported to CMS, 2019-2025
11 companies · $560 in 2025
The $560 reported for 2025 was more than what 97% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.67 · 2022: $60.94 · 2023: $67.87 · 2024: $72.80 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $514.00 | 2025 | Rapiblyk |
| Merck Sharp & Dohme LLC | $131.66 | 2021-2025 | Bridion |
| Teleflex LLC | $31.13 | 2022 | |
| Octapharma USA, INC. | $27.39 | 2025 | Fibryga |
| Takeda Pharmaceuticals U.S.A., INC. | $25.97 | 2024 | Eohilia |
| Abbvie INC. | $19.00 | 2021 | |
| Alcon Vision LLC | $18.19 | 2024 | Hydrus Microstent |
| Regeneron Healthcare Solutions, INC. | $13.63 | 2023 | Dupixent |
| Halozyme INC | $13.17 | 2024 | Hylenex Recombinant |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.65 | 2021 | |
| Masimo Corporation | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Brumley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.